Quantitative Systematic Strategies LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$16.68 - $23.97 $294,718 - $423,525	-17,669 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$14.8 - $21.15 $77,640 - $110,952	5,246 Added 42.23%	17,669 $312,000
Q3 2020 Nov 09, 2020	BUY	$15.21 - $25.53 $188,953 - $317,159	12,423 New	12,423 $190,000
Q1 2020 May 06, 2020	SELL	$11.0 - $19.76 $132,561 - $238,127	-12,051 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$5.24 - $12.96 $63,147 - $156,180	12,051 New	12,051 $133,000
Q3 2018 Nov 14, 2018	SELL	$13.23 - $30.93 $265,327 - $620,301	-20,055 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$16.73 - $20.35 $335,520 - $408,119	20,055 New	20,055 $348,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.